UroToday.com - For many decades, transurethral resection of the prostate (TURP) has been considered the benchmark of surgical management for BPH. The ideal irrigant for TURP would be a nonconductive medium that does not interfere with diathermy, has a high degree of translucency, has osmolality similar to that of serum, and causes only minimal side effects when absorbed. Traditionally, a 1.5% glycine solution is used for irrigation during TURP. The absorption of irrigating fluid is a consistent cause of complications... (Source: Health News from Medical News Today)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

UroToday.com - For many decades, transurethral resection of the prostate (TURP) has been considered the benchmark of surgical management for BPH. The ideal irrigant for TURP would be a nonconductive medium that does not interfere with diathermy, has a high degree of translucency, has osmolality similar to that of serum, and causes only minimal side effects when absorbed. Traditionally, a 1... (Source: Prostate News From Medical News Today)

UroToday.com - Our chapter on BPH in the recent Urologic Clinics of North America focuses on improved methods for defining the etiology of lower urinary tract symptoms (LUTS). The use of patient reported outcome tools (questionnaires) as adjuncts in evaluation of LUTS is highlighted and the purpose, function, and characteristics of each of the more common LUTS questionnaires are discussed in detail. The source and severity of patient symptoms, as well as response to treatment, can be elucidated from questionnaires or combinations thereof beyond what can be obtained from patient histories... (Source: Health News from Medical News Today)

UroToday.com - Our chapter on BPH in the recent Urologic Clinics of North America focuses on improved methods for defining the etiology of lower urinary tract symptoms (LUTS)... (Source: Prostate News From Medical News Today)

Urol Int (DOI:10.1159/000296295) (Source: Urologia Internationalis : Last 20 articles)

Authors: Romics I PMID: 20231135 [PubMed - in process] (Source: Orvosi Hetilap)

Study Type [ndash] Therapy (case series)Level of Evidence 4 To present our experience with single-port transvesical enucleation of the prostate (STEP) in 34 patients with large-volume benign prostatic hyperplasia (BPH). We performed STEP in 34 patients with large volume (>60 g) BPH (mean age 69 years, body mass index 26 kg/m2, and American Society of Anesthesiology class 2). The mean prostate volume estimated by transrectal ultrasonography was 102.5 mL and the mean baseline prostate-specific antigen level was 6.7 ng/mL. A novel single-port device was inserted percutaneously into the bladder through a 2[ndash]3 cm incision in the suprapubic skin crease. After establishing pneumovesicum, the prostate adenoma was enucleated transvesically using standard laparoscopic instruments, and the adeno...MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

This study demonstrates for the first time that GHRH can act as a growth factor in BPH-1 cells and that GHRH antagonists can reverse its stimulatory effect. New observations are provided on the mechanism of action of GHRH antagonists in BPH. Our findings support the merit of further work on the development of GHRH antagonists for therapy of BPH. Prostate © 2010 Wiley-Liss, Inc. (Source: The Prostate)

A prostate-specific antigen (PSA) is widely used as a diagnostic marker for prostate cancer (PC) because of its high specificity. However, elevated serum PSA does not occur only in PC but also in benign prostatic hyperplasia (BPH). Since the structural changes of N-glycans during carcinogenesis are common phenomena, we investigated whether PC-specific N-glycans are linked to PSA. We first analyzed the carbohydrate structures of PSA derived from seminal fluid, serum of BPH and PC patients, and PC cell line, namely, LNCaP using eight lectin-immobilized columns and then with enzyme-linked immunosorbent assay (ELISA). The fraction of serum PSA from PC patients bound to both Fuc1-2Gal and βGalNAc binding Trichosanthes japonica agglutinin-II (TJA-II) column, while that from BPH patients did...

Holmium laser prostate enucleation (HoLEP) appears to be safe and effective for benign prostatic hyperplasia (BPH), based on retrospective data from more than 1000 men reported in the March Journal of Urology. Reuters Health Information (Source: Medscape Urology Headlines)

BERKELEY, CA (UroToday.com) - Our chapter on BPH in the... (Source: UroToday)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

BERKELEY, CA (UroToday.com) - Our chapter on BPH in the... (Source: UroToday)

BERKELEY, CA (UroToday.com) - Our chapter on BPH in the... (Source: UroToday)

BERKELEY, CA (UroToday.com) - Our chapter on BPH in the... (Source: UroToday)

BERKELEY, CA (UroToday.com) - Our chapter on BPH in the... (Source: UroToday)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Treatment with tadalafil for lower urinary tract symptoms in men with benign prostatic hyperplasia does not impair their bladder function, researchers report in the March issue of the Journal of Urology. Reuters Health Information (Source: Medscape Medical News Headlines)

Conclusions. Alfuzosin 10 mg OD administered for 6 months provides a marked and rapid (within 1 week) improvement in LUTS and bother score while improving both ED and EjD. Leungwattanakij S, Watanachote D, Noppakulsatit P, Petchpaibuol T, Choeypunt N, Tongbai T, Wanamkang T, Lojanapiwat B, Permpongkosol S, Tantiwong A, Pripatnanont C, Akarasakul D, Kongwiwatanakul S, and Chotikawanich E. Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine)

SAN FRANCISCO (MedPage Today) -- For men with benign prostatic hyperplasia (BPH), dutasteride (Avodart) both prevents prostate cancer and boosts the predictive power of prostate specific antigen (PSA), researchers affirmed. (Source: MedPage Today Hematology/Oncology)

Prostate cancer TURP procedure. You may be familiar with the TURP (transurethral resection of the prostate) procedure commonly used to treat benign prostatic hyperplasia (BPH), but did you know that it can also be used in men with prostate cancer. (Source: About.com Prostate Cancer)

Systemic inflammation might increase the risk of benign prostatic hyperplasia (BPH), researchers report in a February 8th online paper in the American Journal of Epidemiology. Reuters Health Information (Source: Medscape Urology Headlines)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.